GlobeNewsWire
06 Mar 2026, 14:00 UTC · 32w ago
Verdict
Headline takes no side. We score ZBH −1.00 across four claims — strongly bearish.
−1.00strongly bearish
More negative than 96% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Zimmer Biomet lowered the top end of its full-year organic revenue growth forecast from 4.5% to 4.0%.
So whatGuidance downgrades directly affect valuation and indicate slowing growth momentum.
More negative than 95% of claims this week
Zimmer Biomet attributed financial weakness to a modest slowdown in the U.S. revision market for hips and knees and weakness in restorative therapies.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More negative than 85% of claims this week
The Portnoy Law Firm has initiated an investigation into possible securities fraud against Zimmer Biomet Holdings, Inc.
More negative than 77% of claims this week
Zimmer Biomet reported weakness in Latin America, Emerging Markets in Europe, and non-core businesses.
More negative than 68% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is under investigation for possible securities fraud following a significant stock price drop and lowered revenue forecasts.
More negative than 86% of ticker scores this week
The company is the subject of a legal investigation into possible corporate wrongdoing.
More negative than 86% of ticker scores this week
The company is the subject of a legal investigation into possible corporate wrongdoing.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
1h ago
+5.7%
Price is moving against the score
$98.81 vs $93.45 close before publication (Mar 5) · not market-adjusted
ZBH chart →
